Nasdaq:US$13.48 (+0.30) | HKEX:HK$20.72 (+0.04) | AIM:£2.01 (+0.08)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF